When reviewing the complete blood count report for a child with a febrile illness, a shift to the left is noted because of

Rationale:
A. Aspirin is the mainstay of treatment in Kawasaki disease. It serves two critical purposes: reducing inflammation and fever, and preventing coronary artery aneurysms by inhibiting platelet aggregation. High doses are used initially for anti-inflammatory effects, followed by lower doses for antiplatelet therapy.
B. Corticosteroids may be considered in refractory cases but are not first-line therapy for all patients.
C. Penicillin is not used, as Kawasaki disease is not caused by a bacterial infection.
D. Acetaminophen can reduce fever and discomfort but does not prevent cardiovascular complications and is therefore not sufficient as primary therapy.

Rationale:
A. Isolation from daycare is generally recommended while the child is symptomatic to prevent transmission, but a fixed 7-day period is not always necessary; symptom resolution varies.
B. Antipyretics should be given as needed for fever or discomfort, not routinely every 4 hours for multiple days.
C. Acute bronchiolitis typically presents with symptoms that peak within 1–3 days, with gradual improvement. Most children experience complete resolution within 10–14 days, which is important for caregivers to understand to prevent unnecessary concern or overuse of medications.
D. Antibiotics are not indicated for viral bronchiolitis, even if nasal discharge becomes purulent, as the infection is viral and antibiotics are ineffective.